EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Relief Reports Su

EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Patent Relief Reports Successful Conclusion of Patent Examination Procedure for Patent Application Entitled, 'Vasoactive Intestinal Peptide

Related Keywords

Geneva , Genè , Switzerland , Swiss , Michael Miller , Raghuram Ram Selvaraju , Jack Weinstein , Advita Lifescience Gmb , Linkedin , National Institutes Of Health , Pharma Research , Swiss Exchange , Rx Communications Group , Holding Ag Key , Exchange Commission , News Service , Swiss Patent Office , Reports Successful Conclusion , Patent Examination Procedure , Patent Application Entitled , Vasoactive Intestinal Peptide , Drug Induced Pneumoniti , Therapeutics Reports , Successful Conclusion , Intestinal Peptide , Drug Induced Pneumonitis , Advita Lifescience Gmbh , National Institutes , Quantum Leap , Case Report Publication , New England Journal , License Agreement , Acer Therapeutics , Urea Cycle Disorders , Maple Syrup Urine , Financial Officer , Adhoc , Relief , Herapeutics , Molding , Reports , Uccessful , Conclusion , Patent , Examination , Procedure , Application , Ntitled , Asoactive , Intestinal , Peptide , Treatment , Drug , Induced , Pneumon ,